At close: December 20 at 4:00:01 PM EST
After hours: December 20 at 7:58:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-9,396.6390
-6,408.9310
-8,834.1640
-5,693.3920
-4,028.5410
Financing Cash Flow
8,908.9080
7,605.7720
4,276.6520
15,961.7980
2,567.1390
End Cash Position
6,143.7520
7,438.1350
6,241.2940
10,798.8060
530.4000
Income Tax Paid Supplemental Data
0.9500
0.9500
0.9500
1.4000
3.2720
Interest Paid Supplemental Data
--
--
--
1.4200
56.7070
Issuance of Capital Stock
8,909.5680
7,605.6250
4,276.3650
15,955.5630
268.7500
Issuance of Debt
--
--
--
1,562.7170
3,108.5740
Repayment of Debt
--
--
--
-556.4820
-810.1850
Repurchase of Capital Stock
-0.8280
-0.0400
--
-1,000.0000
--
Free Cash Flow
-9,396.6390
-6,408.9310
-8,834.1640
-5,693.3920
-4,028.5410
12/31/2020 - 8/13/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SPRC SciSparc Ltd.
0.2133
-0.19%
CHRO Channel Therapeutics Corporation
0.6435
-1.45%
WINT Windtree Therapeutics, Inc.
0.3202
-1.48%
PALI Palisade Bio, Inc.
1.7500
-2.78%
QNRX Quoin Pharmaceuticals, Ltd.
0.5690
-12.03%
MTVA MetaVia Inc.
1.6000
-9.09%
ZVSA ZyVersa Therapeutics, Inc.
1.1400
-8.06%
PHIO Phio Pharmaceuticals Corp.
1.7600
+1.15%
IMNN Imunon, Inc.
0.8300
-2.84%
ABVC ABVC BioPharma, Inc.
0.5240
+1.22%